Manipulation of CD44 function with the H90 monoclonal antibody resulted in marked reduction of the leukemic burden in NOD/SCID mice transplanted with primary AML cells through alteration of cell fate and abrogation of leukemic cell homing [32]. Here, CD44 is linked to acute myeloid leukemia.